Nurseta T, Herliawati PA, Harnandari DEP, Handono K, Irwanto Y, Sutrisno S. Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT: Perfoma Risk of Malignancy Index 3 (RMI3) sebagai Prediktor Karsinoma Ovarium Epithelial Stadium Lanjut untuk Pertimbangan Pemberian NACT. Indones J Obstet Gynecol [Internet]. 2022 Jan. 28 [cited 2026 Mar. 2];10(1):42-8. Available from: https://www.inajog.com/index.php/journal/article/view/1599